Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 15 studies | 41% ± 19% | |
| oligodendrocyte precursor cell | 10 studies | 38% ± 16% | |
| glutamatergic neuron | 7 studies | 29% ± 14% | |
| GABAergic neuron | 7 studies | 50% ± 24% | |
| interneuron | 4 studies | 52% ± 21% | |
| GABAergic interneuron | 3 studies | 31% ± 8% | |
| granule cell | 3 studies | 20% ± 5% | |
| GABAergic amacrine cell | 3 studies | 49% ± 14% | |
| glycinergic amacrine cell | 3 studies | 22% ± 4% | |
| retinal ganglion cell | 3 studies | 50% ± 21% | |
| amacrine cell | 3 studies | 36% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 30% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 994.63 | 2635 / 2642 | 96% | 42.78 | 679 / 705 |
| skin | 52% | 294.37 | 944 / 1809 | 4% | 1.09 | 21 / 472 |
| thymus | 0% | 0.23 | 1 / 653 | 37% | 6.08 | 221 / 605 |
| ovary | 2% | 5.12 | 3 / 180 | 24% | 6.36 | 102 / 430 |
| lung | 12% | 22.56 | 71 / 578 | 8% | 1.76 | 91 / 1155 |
| kidney | 1% | 1.18 | 1 / 89 | 18% | 2.34 | 160 / 901 |
| adrenal gland | 0% | 0.78 | 1 / 258 | 8% | 0.93 | 18 / 230 |
| uterus | 4% | 18.20 | 7 / 170 | 3% | 0.75 | 16 / 459 |
| liver | 0% | 0 | 0 / 226 | 6% | 0.79 | 25 / 406 |
| esophagus | 0% | 0.75 | 6 / 1445 | 5% | 0.76 | 9 / 183 |
| breast | 2% | 4.73 | 10 / 459 | 2% | 0.21 | 19 / 1118 |
| adipose | 2% | 6.82 | 27 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 2% | 4.37 | 18 / 803 | 0% | 0 | 0 / 0 |
| stomach | 1% | 1.71 | 4 / 359 | 1% | 0.05 | 3 / 286 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.09 | 1 / 80 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.11 | 6 / 504 |
| intestine | 0% | 0 | 0 / 966 | 1% | 0.30 | 3 / 527 |
| blood vessel | 0% | 0.33 | 1 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051480 | Biological process | regulation of cytosolic calcium ion concentration |
| GO_0051260 | Biological process | protein homooligomerization |
| GO_0071333 | Biological process | cellular response to glucose stimulus |
| GO_0050796 | Biological process | regulation of insulin secretion |
| GO_0032793 | Biological process | positive regulation of CREB transcription factor activity |
| GO_0006171 | Biological process | cAMP biosynthetic process |
| GO_0031915 | Biological process | positive regulation of synaptic plasticity |
| GO_0007611 | Biological process | learning or memory |
| GO_0007616 | Biological process | long-term memory |
| GO_0007165 | Biological process | signal transduction |
| GO_1900454 | Biological process | positive regulation of long-term synaptic depression |
| GO_0071315 | Biological process | cellular response to morphine |
| GO_0071277 | Biological process | cellular response to calcium ion |
| GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO_0051259 | Biological process | protein complex oligomerization |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
| GO_1904322 | Biological process | cellular response to forskolin |
| GO_0071377 | Biological process | cellular response to glucagon stimulus |
| GO_1900273 | Biological process | positive regulation of long-term synaptic potentiation |
| GO_0007626 | Biological process | locomotory behavior |
| GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO_0007613 | Biological process | memory |
| GO_0034199 | Biological process | activation of protein kinase A activity |
| GO_0080135 | Biological process | regulation of cellular response to stress |
| GO_0150076 | Biological process | neuroinflammatory response |
| GO_0038003 | Biological process | G protein-coupled opioid receptor signaling pathway |
| GO_0042593 | Biological process | glucose homeostasis |
| GO_0010255 | Biological process | glucose mediated signaling pathway |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0045121 | Cellular component | membrane raft |
| GO_0016020 | Cellular component | membrane |
| GO_0098686 | Cellular component | hippocampal mossy fiber to CA3 synapse |
| GO_0032809 | Cellular component | neuronal cell body membrane |
| GO_0042734 | Cellular component | presynaptic membrane |
| GO_0030425 | Cellular component | dendrite |
| GO_0044853 | Cellular component | plasma membrane raft |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0048786 | Cellular component | presynaptic active zone |
| GO_0014069 | Cellular component | postsynaptic density |
| GO_0005905 | Cellular component | clathrin-coated pit |
| GO_0030424 | Cellular component | axon |
| GO_0060076 | Cellular component | excitatory synapse |
| GO_0030665 | Cellular component | clathrin-coated vesicle membrane |
| GO_0005901 | Cellular component | caveola |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0008294 | Molecular function | calcium- and calmodulin-responsive adenylate cyclase activity |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0004016 | Molecular function | adenylate cyclase activity |
| GO_0051721 | Molecular function | protein phosphatase 2A binding |
| GO_0003779 | Molecular function | actin binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0005516 | Molecular function | calmodulin binding |
| GO_0046983 | Molecular function | protein dimerization activity |
| Gene name | ADCY8 |
| Protein name | adenylate cyclase (EC 4.6.1.1) Adenylate cyclase type 8 (EC 4.6.1.1) Adenylate cyclase type 8 (EC 4.6.1.1) (ATP pyrophosphate-lyase 8) (Adenylate cyclase type VIII) (Adenylyl cyclase 8) (AC8) (Ca(2+)/calmodulin-activated adenylyl cyclase) Alternative protein ADCY8 |
| Synonyms | HEL-S-172mP hCG_2008967 |
| Description | FUNCTION: Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. . FUNCTION: Catalyzes the formation of cAMP in response to calcium entry leadings to cAMP signaling activation that affect processes suche as synaptic plasticity and insulin secretion. Plays a role in many brain functions, such as learning, memory, drug addiction, and anxiety modulation through regulation of synaptic plasticity by modulating long-term memory and long-term potentiation (LTP) through CREB transcription factor activity modulation. Plays a central role in insulin secretion by controlling glucose homeostasis through glucagon-like peptide 1 and glucose signaling pathway and maintains insulin secretion through calcium-dependent PKA activation leading to vesicle pool replenishment. Also, allows PTGER3 to induce potentiation of PTGER4-mediated PLA2 secretion by switching from a negative to a positive regulation, during the IL1B induced-dedifferentiation of smooth muscle cells. . FUNCTION: Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. . FUNCTION: Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. . |
| Accessions | ENST00000377928.7 E7EVL1 P40145 A0A0K0K1K3 L8E7I7 E5RFR2 ENST00000522949.1 ENST00000286355.10 Q4F7X0 |